搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
qncx
/
财务摘要
Quince Therapeutics Inc
QNCX
添加自选
29.360
USD
+2.640
+9.88%
收盘 10-08 16:00(美东)
28.77M
总市值
1.30
市盈率 TTM
Quince Therapeutics Inc
29.360
+2.640
+9.88%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
QNCX 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Quince Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
28.77M
股息TTM
0.00
市盈率 TTM
1.30
每股收益TTM
22.66
营业收入
--
净利润
-56.83M
净资产收益率
-192.90%
总资产收益率
-49.42%
Quince Therapeutics Inc 财报日历
最新发布
8月 14, 2026
每股收益 / 预测值
-12.31
/-17.88
营业收入 / 预测值
--
/0.00
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-258.06%
-12.31
2402.35%
78.75
-149.00%
-7.09
-95.81%
-2.49
46.57%
-3.44
-31.95%
-3.42
-31.59%
-2.85
14.22%
-1.27
-373.00%
-6.43
-658.49%
-2.59
-1295.65%
-2.16
--
-1.48
--
-1.36
--
-0.34
--
-0.15
--
-1.41
--
--
--
--
--
--
--
--
净利润
-370.36%
-75.49M
338.94%
35.91M
-216.73%
-39.46M
-144.76%
-13.44M
42.12%
-16.05M
-34.81%
-15.03M
-40.07%
-12.46M
-2.64%
-5.49M
-467.52%
-27.73M
9.02%
-11.15M
-60.72%
-8.89M
32.45%
-5.35M
70.50%
-4.89M
43.38%
-12.25M
76.35%
-5.53M
63.51%
-7.92M
23.86%
-16.56M
6.26%
-21.64M
-13.84%
-23.40M
-0.93%
-21.71M
资产负债率
-100.00%
0.00%
-100.00%
0.00%
54.07%
19.27%
35.38%
15.94%
41.27%
14.49%
67.98%
14.26%
56.41%
12.51%
--
11.78%
--
10.26%
--
8.49%
10835.48%
8.00%
--
0.00%
--
0.00%
--
0.00%
--
0.07%
--
0.09%
--
--
--
--
--
--
--
--
利润表
营业利润
-114.52%
-21.23M
24.84%
-9.72M
-60.61%
-16.24M
-32.97%
-11.36M
-11.91%
-9.89M
-49.13%
-12.93M
-21.17%
-10.11M
-40.24%
-8.55M
-58.35%
-8.84M
-22.92%
-8.67M
-32.03%
-8.34M
10.32%
-6.09M
65.65%
-5.58M
67.73%
-7.06M
73.16%
-6.32M
68.65%
-6.79M
25.36%
-16.26M
6.22%
-21.86M
-12.91%
-23.54M
1.07%
-21.68M
净利润
-370.36%
-75.49M
338.94%
35.91M
-216.73%
-39.46M
-144.76%
-13.44M
42.12%
-16.05M
-34.81%
-15.03M
-40.07%
-12.46M
-2.64%
-5.49M
-467.52%
-27.73M
9.02%
-11.15M
-60.72%
-8.89M
32.45%
-5.35M
70.50%
-4.89M
43.38%
-12.25M
76.35%
-5.53M
63.51%
-7.92M
23.86%
-16.56M
6.26%
-21.64M
-13.84%
-23.40M
-0.93%
-21.71M
资产负债表
流动资产
230.46%
123.41M
-24.38%
25.58M
-48.01%
22.90M
-43.54%
29.20M
-41.13%
37.34M
-51.97%
33.83M
-43.14%
44.04M
-39.28%
51.72M
-28.36%
63.44M
-23.84%
70.44M
-17.40%
77.44M
-13.33%
85.17M
-10.89%
88.55M
-4.01%
92.49M
-16.05%
93.75M
-17.71%
98.28M
-26.85%
99.37M
-35.72%
96.35M
-19.00%
111.67M
-16.47%
119.43M
流动负债总额
13.83%
8.50M
4.93%
8.77M
493.93%
43.23M
380.07%
26.04M
-27.65%
7.47M
-15.06%
8.36M
-23.97%
7.28M
140.79%
5.42M
428.74%
10.32M
215.83%
9.84M
211.89%
9.57M
-54.44%
2.25M
-67.19%
1.95M
-67.92%
3.12M
-78.42%
3.07M
-65.06%
4.95M
-67.90%
5.95M
-45.65%
9.71M
-16.32%
14.22M
-13.74%
14.15M
总资产
5.79%
124.00M
-75.14%
26.62M
-18.30%
93.52M
-13.14%
109.90M
-13.07%
117.21M
-32.77%
107.09M
-31.82%
114.48M
48.17%
126.52M
51.77%
134.83M
70.70%
159.29M
61.58%
167.90M
-22.22%
85.39M
-24.63%
88.84M
-19.64%
93.32M
-22.01%
103.91M
-25.53%
109.78M
-26.97%
117.86M
-33.46%
116.13M
-29.68%
133.23M
-27.97%
147.42M
总负债
-85.30%
15.51M
-87.63%
10.95M
53.25%
129.24M
33.40%
108.84M
20.05%
105.47M
3.99%
88.51M
1.83%
84.33M
3521.26%
81.59M
4401.08%
87.86M
2632.42%
85.11M
2396.71%
82.82M
-57.05%
2.25M
-69.17%
1.95M
-68.05%
3.12M
-77.35%
3.32M
-64.47%
5.25M
-67.21%
6.33M
-45.95%
9.75M
-14.89%
14.64M
-11.34%
14.76M
总权益
824.40%
108.49M
-15.66%
15.67M
-218.47%
-35.71M
-97.64%
1.06M
-75.01%
11.74M
-74.95%
18.58M
-64.57%
30.15M
-45.95%
44.93M
-45.94%
46.97M
-17.77%
74.18M
-15.42%
85.08M
-20.47%
83.13M
-22.10%
86.88M
-15.21%
90.20M
-15.17%
100.59M
-21.20%
104.53M
-21.50%
111.53M
-32.02%
106.38M
-31.16%
118.59M
-29.44%
132.65M
现金流量表
经营净额
-65.46%
-18.89M
20.56%
-7.63M
-38.78%
-10.48M
-36.75%
-9.93M
-30.62%
-11.41M
-14.94%
-9.60M
-24.25%
-7.55M
-50.68%
-7.26M
-128.35%
-8.74M
-134.04%
-8.35M
-4.16%
-6.08M
28.06%
-4.82M
75.17%
-3.83M
77.82%
-3.57M
59.53%
-5.83M
61.38%
-6.70M
12.23%
-15.41M
-18.23%
-16.09M
-8.60%
-14.42M
-40.18%
-17.34M
投资净额
32.49%
8.00M
10.11%
12.00M
-25.73%
8.07M
-125.07%
-1.78M
221.31%
6.04M
22.26%
10.90M
101.61%
10.87M
95.46%
7.11M
75.51%
-4.98M
60.90%
8.91M
-71.12%
5.39M
141.19%
3.63M
-287.03%
-20.32M
-58.70%
5.54M
-10.77%
18.67M
-1252.22%
-8.83M
-193.37%
-5.25M
-57.61%
13.41M
32.18%
20.92M
-92.61%
766.00K
融资净额
655.85%
108.93M
10754.02%
9.44M
--
2.03M
127.52%
1.38M
41077.14%
14.41M
-54.21%
87.00K
-100.00%
0.00
-50100.00%
-5.00M
34.62%
35.00K
280.00%
190.00K
416.67%
57.00K
300.00%
10.00K
-75.93%
26.00K
-91.96%
50.00K
-101.82%
-18.00K
-100.11%
-5.00K
-83.93%
108.00K
41.04%
622.00K
2100.00%
990.00K
5127.78%
4.71M
常见问题
Quince Therapeutics Inc的流动资产是多少?
根据Quince Therapeutics Inc的FY2025财报,流动资产为22.90M(同比变化-48.01)。
Quince Therapeutics Inc的总资产是多少?
根据Quince Therapeutics Inc的FY2025财报,Quince Therapeutics Inc的总资产为93.52M(同比变化-18.30)。
Quince Therapeutics Inc的总负债是多少?
根据Quince Therapeutics Inc的FY2025财报,Quince Therapeutics Inc的总负债为129.24M(同比变化53.25)。
Quince Therapeutics Inc的总权益是多少?
根据Quince Therapeutics Inc的FY2025财报,Quince Therapeutics Inc的总权益为-35.71M(同比变化-218.47)。
Quince Therapeutics Inc的净营业收入是多少?
根据Quince Therapeutics Inc的FY2025财报,Quince Therapeutics Inc的净营业收入为-50.43M(同比变化-39.42)。
Quince Therapeutics Inc的净投资是多少?
根据Quince Therapeutics Inc的FY2025财报,Quince Therapeutics Inc的净投资为23.23M(同比变化6.02)。
Quince Therapeutics Inc的净融资是多少?
根据Quince Therapeutics Inc的FY2025财报,Quince Therapeutics Inc的净融资为17.91M(同比变化475.06)。
Quince Therapeutics Inc的每股收益(EPS)是多少?
根据Quince Therapeutics Inc的FY2025财报,每股收益(EPS)为-335.27(同比变化-2452.33)。
Quince Therapeutics Inc的净利润是多少?
根据Quince Therapeutics Inc的FY2025财报,净利润为-83.98M(同比变化-47.78)。
Quince Therapeutics Inc的债务与资产比率是多少?
根据Quince Therapeutics Inc的FY2025财报,债务与资产比率为19.27(同比变化54.07)。
Quince Therapeutics Inc的资产回报率(ROA)是多少?
根据Quince Therapeutics Inc的FY2025财报,资产回报率(ROA)为-80.75(同比变化-100.62)。
Quince Therapeutics Inc的营业利润是多少?
根据Quince Therapeutics Inc的FY2025财报,营业利润为-50.43M(同比变化-39.42)。